HNPCC Tumor Screening (MSI/IHC)

See Cepmed’s Personalized Medicine Portal for more information about this test

Read More

Select your province to learn about access to testing & services in your area.

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Overview

Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS), is the most common hereditary cause of colon cancer, accounting for 2-5% of all colorectal cancers. Molecular testing of tumor tissue such as immunohistochemistry (IHC) and microsatellite instability (MSI) can be used to identify individuals at increased risk for HNPCC. Follow the Read More button above to learn more.

Testing may be provided through a public laboratory in your province, in another province. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources